| 000 | 01833 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250518090949.0 | ||
| 264 | 0 | _c20210408 | |
| 008 | 202104s 0 0 eng d | ||
| 022 | _a1097-0215 | ||
| 024 | 7 |
_a10.1002/ijc.32951 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHellmann, Matthew D | |
| 245 | 0 | 0 |
_aPhase 1 study of epacadostat in combination with atezolizumab for patients with previously treated advanced nonsmall cell lung cancer. _h[electronic resource] |
| 260 |
_bInternational journal of cancer _c10 2020 |
||
| 300 |
_a1963-1969 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Intravenous |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aOximes _xadministration & dosage |
| 650 | 0 | 4 |
_aSulfonamides _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aGettinger, Scott | |
| 700 | 1 | _aChow, Laura Q M | |
| 700 | 1 | _aGordon, Michael | |
| 700 | 1 | _aAwad, Mark M | |
| 700 | 1 | _aCha, Edward | |
| 700 | 1 | _aGong, Xiaohua | |
| 700 | 1 | _aZhou, Gongfu | |
| 700 | 1 | _aWalker, Chris | |
| 700 | 1 | _aLeopold, Lance | |
| 700 | 1 | _aHeist, Rebecca S | |
| 773 | 0 |
_tInternational journal of cancer _gvol. 147 _gno. 7 _gp. 1963-1969 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ijc.32951 _zAvailable from publisher's website |
| 999 |
_c30712263 _d30712263 |
||